The Evolving Role of Warfarin in the Era of Direct Oral Anticoagulants for Deep Vein Thrombosis
Introduction Deep vein thrombosis (DVT) is a major component of venous thromboembolism (VTE), which remains a major cause of cardiovascular morbidity and mortality worldwide. For a long time, oral anticoagulation therapy was based entirely on vitamin K antagonists (VKAs) such as warfarin [1]. Warfarin has repeatedly proven its strong clinical efficacy in preventing recurrence of … Read more